Topic Archives: radiotherapy

That’s a mysterious headline, right? The pitch we’re looking at today is from Dave Lashmet at Stansberry, who’s selling his Stansberry Venture newsletter for $5,000 — and the carrot he’s dangling to get you to subscribe is this “most disruptive biotech discovery” … which, it turns out, is a form of radiation therapy that, in […]

Comments

  • Avatar

    Any chance it could be Theralase? Not radiotherapy but photodynamic compounds and lasers. Two patients cancer free at 54...

  • Avatar

    Check this interview by VRAY CEO: https://stocknewsnow.com/showcommentary.php?newsartid=ANEWSID15122015100001&title=...

  • Avatar

    $CLRB Dr. KSS I understand the frustration but it really has not been that long and does it not deserve a call to ...

  • Avatar

    $RXDX long Layman question. I'm curious how the following passage squares with the otherwise positive results: "The pat...

  • DrKSSMDPhD

    For $CLRB longs, would-be longs, and people who attended Friday's call: Pursuant to what we discussed I reached out to J...

  • Avatar

    $TRIL, #CD47: A significant scientific discovery with potential clinical implications: Stanford researchers devise ne...

  • Avatar

    $ATNM As we all know by now, today was a bad day for ATNM. Once again I think it was the result of investors expecting...

  • Avatar

    HN, this is where the youth and vigor of the patient come in... A younger patient (down to a point) may be able to toler...

  • Avatar

    DBMD, $ATNM Forgive the copy and paste.... But Note my edits regarding [conventional radiotherapy concepts]. When e...

  • Avatar

    Any thoughts on this company Progenics Pharma (PGNX)? Deals with Salix and Valeant for Relistor which treats opioid indu...

  • Avatar

    a very good article. I appreciated learning about the updates to radiotherapy since I was last a patient and specificall...

  • Avatar

    Hello, Accuray makes radiotherapy machine which they call "tomotherapy". This machines treats cancer patients. The mai...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info